Future investigations should be focused on exploring whether IFNα-MSC administration could optimize the efficacies of other anti-tumor strategies, such as tumor vaccination, radiotherapy, and chemotherapy [42–44]. This evidence concerns the gene IFNA1 and neoplasm.